Johnson & Johnson Stock Upgraded Despite $8 Billion Risperdal Verdict: What You Need to...

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Oct 12, 2019 at 12:32 PM.

  1. #1 cafead, Oct 12, 2019 at 12:32 PM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    33,028
    Likes Received:
    3
    via Johnson & Johnson (NYSE: JNJ) is a massive medical products conglomerate. But skimming through the headlines it's been producing lately, you'd almost think it was a law firm -- a really bad law firm, that loses a lot of cases:

    article source
     
    Quote

Reply to Thread